303 related articles for article (PubMed ID: 26453442)
1. Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.
De Falco G; Ambrosio MR; Fuligni F; Onnis A; Bellan C; Rocca BJ; Navari M; Etebari M; Mundo L; Gazaneo S; Facchetti F; Pileri SA; Leoncini L; Piccaluga PP
BMC Cancer; 2015 Oct; 15():668. PubMed ID: 26453442
[TBL] [Abstract][Full Text] [Related]
2. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
[TBL] [Abstract][Full Text] [Related]
3. Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma.
Oduor CI; Kaymaz Y; Chelimo K; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
BMC Cancer; 2017 Nov; 17(1):761. PubMed ID: 29132323
[TBL] [Abstract][Full Text] [Related]
4. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.
Aukema SM; Kreuz M; Kohler CW; Rosolowski M; Hasenclever D; Hummel M; Küppers R; Lenze D; Ott G; Pott C; Richter J; Rosenwald A; Szczepanowski M; Schwaenen C; Stein H; Trautmann H; Wessendorf S; Trümper L; Loeffler M; Spang R; Kluin PM; Klapper W; Siebert R;
Haematologica; 2014 Apr; 99(4):726-35. PubMed ID: 24179151
[TBL] [Abstract][Full Text] [Related]
5. Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases.
Mundo L; Ambrosio MR; Raimondi F; Del Porro L; Guazzo R; Mancini V; Granai M; Jim Rocca B; Lopez C; Bens S; Onyango N; Nyagol J; Abinya N; Navari M; Ndede I; Patel K; Paolo Piccaluga P; Bob R; de Santi MM; Russell RB; Lazzi S; Siebert R; Stein H; Leoncini L
Blood Cancer J; 2019 Nov; 9(12):91. PubMed ID: 31748534
[TBL] [Abstract][Full Text] [Related]
6. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.
Onnis A; De Falco G; Antonicelli G; Onorati M; Bellan C; Sherman O; Sayed S; Leoncini L
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20930934
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
[TBL] [Abstract][Full Text] [Related]
8. LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas.
Colomo L; Vazquez I; Papaleo N; Espinet B; Ferrer A; Franco C; Comerma L; Hernandez S; Calvo X; Salar A; Climent F; Mate JL; Forcada P; Mozos A; Nonell L; Martinez A; Carrio A; Costa D; Dlouhy I; Salaverria I; Martin-Subero JI; Lopez-Guillermo A; Valera A; Campo E;
Am J Surg Pathol; 2017 Jul; 41(7):877-886. PubMed ID: 28288039
[TBL] [Abstract][Full Text] [Related]
9. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
[TBL] [Abstract][Full Text] [Related]
10. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
[TBL] [Abstract][Full Text] [Related]
11. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
12. New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing.
Greenough A; Dave SS
Curr Opin Hematol; 2014 Jul; 21(4):326-32. PubMed ID: 24867287
[TBL] [Abstract][Full Text] [Related]
13. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.
Li Z; Van Calcar S; Qu C; Cavenee WK; Zhang MQ; Ren B
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8164-9. PubMed ID: 12808131
[TBL] [Abstract][Full Text] [Related]
14. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
Boerma EG; Siebert R; Kluin PM; Baudis M
Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation.
Sevilla DW; Gong JZ; Goodman BK; Buckley PJ; Rosoff P; Gockerman JP; Lagoo AS
Am J Clin Pathol; 2007 Dec; 128(6):981-91. PubMed ID: 18024324
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma.
Erikson J; ar-Rushdi A; Drwinga HL; Nowell PC; Croce CM
Proc Natl Acad Sci U S A; 1983 Feb; 80(3):820-4. PubMed ID: 6402776
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
18. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.
Hummel M; Bentink S; Berger H; Klapper W; Wessendorf S; Barth TF; Bernd HW; Cogliatti SB; Dierlamm J; Feller AC; Hansmann ML; Haralambieva E; Harder L; Hasenclever D; Kühn M; Lenze D; Lichter P; Martin-Subero JI; Möller P; Müller-Hermelink HK; Ott G; Parwaresch RM; Pott C; Rosenwald A; Rosolowski M; Schwaenen C; Stürzenhofecker B; Szczepanowski M; Trautmann H; Wacker HH; Spang R; Loeffler M; Trümper L; Stein H; Siebert R;
N Engl J Med; 2006 Jun; 354(23):2419-30. PubMed ID: 16760442
[TBL] [Abstract][Full Text] [Related]
19. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.
Richter J; Schlesner M; Hoffmann S; Kreuz M; Leich E; Burkhardt B; Rosolowski M; Ammerpohl O; Wagener R; Bernhart SH; Lenze D; Szczepanowski M; Paulsen M; Lipinski S; Russell RB; Adam-Klages S; Apic G; Claviez A; Hasenclever D; Hovestadt V; Hornig N; Korbel JO; Kube D; Langenberger D; Lawerenz C; Lisfeld J; Meyer K; Picelli S; Pischimarov J; Radlwimmer B; Rausch T; Rohde M; Schilhabel M; Scholtysik R; Spang R; Trautmann H; Zenz T; Borkhardt A; Drexler HG; Möller P; MacLeod RA; Pott C; Schreiber S; Trümper L; Loeffler M; Stadler PF; Lichter P; Eils R; Küppers R; Hummel M; Klapper W; Rosenstiel P; Rosenwald A; Brors B; Siebert R;
Nat Genet; 2012 Dec; 44(12):1316-20. PubMed ID: 23143595
[TBL] [Abstract][Full Text] [Related]
20. Expression of cellular myc and mos genes in undifferentiated B cell lymphomas of Burkitt and non-Burkitt types.
Maguire RT; Robins TS; Thorgeirsson SS; Heilman CA
Proc Natl Acad Sci U S A; 1983 Apr; 80(7):1947-50. PubMed ID: 6300881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]